RxDoctor Payments DataLook up a doctor →

Sally de Castro Tilsen

Physician Assistant · Newport Beach, CANPI 1023282019

Payments from drug & device makers

$76,693in general payments, 2019–2025

Across 1,436 payments — averaging $53.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$48K
  • UCB, Inc.$4K
  • Teva Pharmaceuticals USA, Inc.$4K
  • Neurocrine Biosciences, Inc.$2K
  • Axsome Therapeutics, Inc.$2K
  • Lilly USA, LLC$2K
  • plus $15K from 49 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)392$48,335
UCB, Inc.137$4,188
Teva Pharmaceuticals USA, Inc.138$3,822
Neurocrine Biosciences, Inc.86$2,239
Axsome Therapeutics, Inc.69$1,741
Lilly USA, LLC48$1,530
Pfizer79$1,522
Amgen(2 entities)42$1,451
AstraZeneca(2 entities)40$1,222
Lundbeck LLC25$952
Livanova USA, Inc.22$833
Upsher-smith Laboratories LLC37$660
Biohaven Pharmaceutical Holding Company Ltd.37$653
Eisai Inc.18$622
Amneal Pharmaceuticals LLC13$520
Biohaven Pharmaceuticals, Inc.27$498
Collegium Pharmaceutical, Inc.27$475
Johnson & Johnson(2 entities)16$452
Idorsia Pharmaceuticals US Inc14$427
SK Life Science, Inc.17$398
Alnylam Pharmaceuticals Inc.10$327
Impel Pharmaceuticals Inc.9$287
Tonix Medicines, Inc.16$268
Avadel CNS Pharmaceuticals, LLC2$245
Alkermes, Inc.2$242
Scilex Pharmaceuticals Inc.12$225
Abbott2$223
Tanabe Pharma America, Inc.9$213
EMD Serono, Inc.2$157
Jazz Pharmaceuticals Inc.4$155
Kyowa Kirin, Inc.2$143
Azurity Pharmaceuticals, Inc.8$132
Almatica Pharma LLC7$131
Avanir Pharmaceuticals, Inc.5$119
Takeda Pharmaceuticals U.S.A., Inc.6$112
Impel Pharmaceuticals LLC5$111
Supernus Pharmaceuticals, Inc.6$107
Biogen4$104
Merck6$102
Arbor Pharmaceuticals, Inc.5$78
Acadia Pharmaceuticals Inc3$75
Currax Pharmaceuticals LLC5$72
Harmony Biosciences LLC1$65
Valinor Pharma, LLC3$58
Bausch Health US, LLC3$55
Vertex2$51
Forte Bio-pharma LLC2$49
Argenx US, Inc.2$49
Otsuka America Pharmaceutical, Inc.2$36
Genentech USA, Inc.1$30
Averitas Pharma Inc.1$30
Endo Pharmaceuticals Inc.2$28
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$25
Redhill Biopharma Inc.1$24
Alfasigma USA, Inc.1$23

How this compares

$76,693 in reported general payments places this provider in the 95th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California →

Medicare billing

Part B allowed, 2024
$289,132
Medicare patients
204
Services billed
37,254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Newport Beach

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →